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Summary: The hypoglycaemic effect of aqueous leaf extract of Murraya koenigii was studied in normal 
and alloxan- induced diabetic rats. The extract was administered orally at 100 mg/Kg, 150 mg/Kg and 200 
mg/Kg bodyweight each to respective groups of animals (Groups I, II and III) for seven days. Group IV 
received normal saline and served as control for the normal rats. For the alloxan-induced diabetic rats, the 
same dosage pattern was administered to three groups of rats for seven days (Groups V, VI and VII) while 
group VIII which received normal saline served as control. At the various dose levels administered, the 
glucose lowering effect was more pronounced in the alloxan-diabetic rats than in control rats. When 
compared with chlorpropamide, the glucose lowering effect of aqueous extract of Murraya koenigii was 
significantly (p <0.05) lower at the dose levels administered in both normal and alloxan-diabetic rats.  
 




Diabetes mellitus is a metabolic disorder of 
multiple aetiology characterized by chronic 
hyperglycaemia with disturbances of 
carbohydrate, fat and protein metabolism 
resulting from defects in insulin secretion, insulin 
action or both. Management of this disease may 
include lifestyle modifications, diet, exercise, 
long – term use of oral hypoglycaemic agents or 
insulin therapy.  
Since ancient times, plants have been an 
exemplary source of medicine. The search for 
plants with hypoglycaemic property is an area 
that draws attention of research workers globally. 
Grover et al. (2002) reviewed 45 of such plants 
and their products that have been mentioned/used 
in the Indian traditional system of medicine. 
Literature reports have indicated that the use of 
Momordica foetida (Olaniyi, 1980), Disocorea 
dumentorum (Iwu et al., 1990a), Garcina kola 
(Iwu et al., 1990b), etc as antidiabetic agents in 
Nigeria.  
Murraya koengii is a small deciduous tree 
with very pungent aromatic leaves (curry leaf) 
belonging to the family Rutaceae of trees. The 
family includes plants throughout tropical zones 
on most continents and includes approximately 
1500 genera and 1500 species. In Kano State, 
curry leaf is used traditionally as a stimulant, anti-
dysenteric and for management of diabetes 
mellitus. Even though, literature reports 
elsewhere (Khan et al., 1995) indicate that 
Murraya koengii possess hypoglycaemic 
property, the plant has not been subjected to 
scientific investigation (in the context in which it 
is used) in Kano State. Therefore, this work is 
aimed at investigating the hypoglycaemic effect 
of aqueous extract of Murraya keonigii and its 
effect on serum lipid levels in normal and alloxan 
– diabetic rats.   
 
Materials and Methods 
Plants materials/preparation of the extract 
Fresh leaves of the plant (Murraya koenigii) 
were obtained locally from a farmer in Kano 
metropolis. The leaf was identified by a staff of 
the Botany Unit, Bayero University, Kano. 
Aqueous leaf extract was prepared as described 
by Sofowora (1984). The fresh leaves were oven-
dried at 45
0
C for 3 days, ground into power and 
20g soaked in 300ml of distilled water overnight 
at room temperature. The filtrate obtained was 
evaporated to constant weight in a hot-air oven at 
45
0
C for 4 days and the yield of the extract was 
approximately 60%. The extract was weighed 
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(2g) and reconstituted in appropriate volume of 
distilled water before administration to the rats. 
 
Animals 
Adult male wistar rats weighing between 
150- 200g, obtained from the National Veterinary 
Research Institute (NVRI), Vom, Plateau state, 
Nigeria were used. The animals were allowed free 
access to food and water. Grower’s mash was 
used to feed the animals throughout the study 
period. The rats were divided into eight groups of 
five rats per group. Groups I, II, III were 
administered aqueous leaf extract of Murraya 
koenigii at dose levels of 100mg/kg, 150mg/kg 
and 200mg/kg body weight respectively. Group 
IV received normal saline only and served as 
control for the normal rats. 
Experimental diabetes was induced in the 
hyperglycaemic group with alloxan- (sigma) 
administered intraperitoneally at a dose of 
100mg/kg. Rats were left for a period of four days 
prior to commencement of extract administration. 
Groups V, VI and VII were administered orally 
aqueous leaf extract of M. koenigii at dose levels 
of 100 mg/Kg, 150 mg/Kg and 200 mg/Kg 
bodyweight respectively. Group VIII received 
normal saline only and served as control for the 
alloxan – induced rats.  
 
Blood collection and Biochemical Analysis  
At the end of seven days period of extract 
administration, the rats were sacrificed. Blood 
samples were collected from the heart region 
directly into anticoagulant bottles and later 
plasma was collected after centrifugation. 
DIALAB® Diagnostic reagent kit was used to 
estimate plasma glucose concentration. Plasma 
triglyceride concentration was also determined 
using DIALAB® diagnostic reagent kit, while 
total cholesterol concentration was estimated 
using RANDOX® kit (catalogue No: CH 200). 
HDL – cholesterol was estimated in the 
supernatant left after precipitating very low 
density lipoproteins (VLDL) and low density 
lipoproteins (LDL) using magnesium 
chloride/phosphotungstic acid, was used to 
estimate plasma high density lipoprotein 
cholesterol (HDL – CH) using RANDOX®  kit 
(catalogue No: CH 200). LDL – Cholesterol was 
calculated by Friedwald’s formula (Friedwald et 
al., 1972).  
 
Acute Toxicity  
Various doses (80 mg/Kg, 400 mg/Kg and 
2000 mg/Kg) of aqueous leaf extract of M. 
koenigii were administered intraperitoneally to 
respective groups of rats. A control group were 
administered intraperitoneally normal saline. Rats 
were observed closely for toxic symptoms and 
behavioural changes for the first 2 hours of 
administration and mortality recorded within 24 
hours.  
 
Statistical Analysis  
Fischer’s ‘t’ test was used for statistical analysis.  
 
 
Table 1: Effect of aqueous leaf extract of Murraya koenigii on serum glucose and serum lipids in normal 
rats after 7 days of administration  
 








HDL – CH  
(mmol/) 
LDL – CH  
(mmol/e) 
Group I 




4.19 ± 0.13 
 
*1.89 ± 0.43 
 
2.37 ± 0.22 
 
0.54 ± 0.10 
 
1.46 ± 0.09 
Group II 




*3.80 ± 0.13 
 
2.14 ± 0.43 
 










*3.27 ± 0.13 
 
3.22 ± 0.97 
 
4.31 ± 0.78 
 










3.39 ± 0.38 
 
3.23 ± 1.94 
 
0.73 ± 0.33 
 
1.82 ± 1.54 
 
Results are mean + standard deviation, n = number of animals. *significantly different from controls at p 
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Table 2: Effect of aqueous leaf extract of Murraya koenigii on serum glucose and serum lipids in alloxan – 
induced rats after 7 days of administration 
  









HDL – CH  
(mmol/l) 
LDL – CH  
(mmol/e) 
Group V 




*3.27 + 0.12 
 
4.89 + 0.38 
 
4.10 + 0.94 
 
0.61 + 0.30 
 
2.50 + 0.75 
Group VI 




*2.75 + 0.23 
 
4.14 + 0.50 
 
5.60 + 0.94 
 
0.81 + 0.30 
 
3.97 + 0.59 
Group VII 




*2.23 + 0.13 
 
2.64 + 0.14 
 
4.31 + 1.69 
 
0.73 + 0.30 
 
3.05 + 1.36 
Group VIII 




4.32 + 0.23 
 
4.18 + 0.58 
 
5.17 + 1.12 
 
0.92 + 0.12 
 
3.63 + 1.45 
Results are mean + standard deviation, n = number of animals. *significantly different from controls at p < 0.05       
 
 
Table 3: Comparison of the glucose lowering effect of aqueous leaf extract of Murraya koenigii between 
normal and alloxan – diabetic rats   
 
Animals  Group I  
N 
Group V  
ALD 
Group II  
N 
Group VI  
ALD 
Group III  
N 




4.19* + 0.13 3.27* + 0.12 3.80* + 0.13 2.75* + 0.23 3.27* + 0.13 2.23 + 0.13 
Results are mean + standard deviation, n = number of animals. *significantly different at p < 0.05 N = normal, ALD = 
alloxan – diabetic  
 
Results and Discussion  
Table 1 presents the effect of aqueous 
extract of M. keonigii on plasma glucose and 
serum lipids in normal rats after seven days of 
administration. Plasma glucose levels decreased 
in a dose – dependent manner from Group I to 
Group III and the levels were lower than the level 
in the control group (Group IV). The differences 
in plasma glucose levels between Groups II, III 
and Group IV (control) were statistically 
significant (P <0.05). The difference in the 
plasma triglyceride level between Group I and 
Group IV was also statistically significant (P < 
0.05). Plasma TC, HDL – CH, and LDL – CH 
levels did not differ in any clear trend between the 
groups.  
In alloxan – diabetic rats, the aqueous 
extract of M. keonigii had the same effect on 
plasma glucose levels as in normal rats (Table 2). 
Plasma glucose levels decreased significant (P 
<0.05) between Group V, VI, VII and Group VIII 
(control). Plasma triglyceride differed 
significantly (P < 0.05) between Group VII and 
Group VIII (control). At the dose levels 
administered, the glucose lowering effect of 
aqueous extract of Murraya keonigii was 
significantly higher (P <0.05) in alloxan – 
diabetic rats than in normal rats (Table 3). No 
mortality was recorded during acute toxicity 
study up to a dose of 2000mg/Kg (Table 4).   
 
Table 4: Data on mortality in rats after acute treatment 
with aqueous leaf extract of M. koenigii 
 
 Dose (mg/Kg 
bodyweight) 
No. of rats  Mortality  
Control  4 0 
80 4 0 
400 4 0 
200 4 0 
 
The findings of this study suggest that 
Murraya keonigii aqueous leaf extract possesses 
hypoglycaemic activity in normal and alloxan – 
induced diabetic rats. This result agrees with 
earlier reports (Khan et al., 1995; Grover et al., 
2002 and Kesari et al., 2005). However, this 
result contradicts the report of Adebayo et al. 
(2004) which refuted the antidiabetic 
ethnomedical claim of M. keonigii. Although, the 
extract showed antidiabetic properties, its activity 
was less than that of chlorpropamide at all doses 
administered. Therefore, the plant extract cannot 
be used as a substitute for conventional 
antidiabetic drugs.  
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It has been suggested that M. koenigii acts 
by decreasing glycogenesis and gluconeogenesis 
(Khan et al., 1995). However, characterization of 
the active principle responsible for the 
hypoglycaemic activity of M. keonigii has not yet 
been done. As no mortality was recorded within 
24 hours during the acute toxicity test, LD50 could 
not be calculated. The non – toxic effect of the 
aqueous leaf extract of M. koenigii (Table 4) lend 
support to the widespread use of the plant as a 
spice for food flavouring. It is also interesting to 
note that the glucose lowering effect of aqueous 
leaf extract of M. koenigii was higher in alloxan – 
induced diabetic animals than in normoglycaemic 
animals (Table 3). This finding may form a basis 
for the inclusion of M. koenigii as a spice in the 
dietary management of diabetes mellitus. 
However, this postulate is open for further 
investigation.      
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